Business Description
PCI Biotech Holding ASA
NAICS : 325412
SIC : 2834
ISIN : NO0010405640
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 64.29 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 34.3 | |||||
3-Year EPS without NRI Growth Rate | 34.7 | |||||
3-Year FCF Growth Rate | 42.2 | |||||
3-Year Book Growth Rate | -40.9 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.86 | |||||
Quick Ratio | 6.86 | |||||
Cash Ratio | 5.67 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.96 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -29.82 | |||||
ROA % | -26.23 | |||||
ROIC % | -281.21 | |||||
ROC (Joel Greenblatt) % | -904.96 | |||||
ROCE % | -31.03 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.52 | |||||
Price-to-Tangible-Book | 1.51 | |||||
EV-to-EBIT | -1.52 | |||||
EV-to-EBITDA | -1.54 | |||||
EV-to-FCF | -1.71 | |||||
Price-to-Net-Current-Asset-Value | 1.55 | |||||
Price-to-Net-Cash | 1.93 | |||||
Earnings Yield (Greenblatt) % | -65.79 | |||||
FCF Yield % | -22.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
PCI Biotech Holding ASA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -0.314 | ||
Beta | 0.36 | ||
Volatility % | 36.24 | ||
14-Day RSI | 0 | ||
14-Day ATR (kr) | 0.01923 | ||
20-Day SMA (kr) | 1.8491 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (kr) | 1.798 - 2.82 | ||
Shares Outstanding (Mil) | 37.33 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
PCI Biotech Holding ASA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
PCI Biotech Holding ASA Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
PCI Biotech Holding ASA Frequently Asked Questions
What is PCI Biotech Holding ASA(LTS:0JGL)'s stock price today?
When is next earnings date of PCI Biotech Holding ASA(LTS:0JGL)?
Does PCI Biotech Holding ASA(LTS:0JGL) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |